Wird geladen...
JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients
The use of Natalizumab in Multiple Sclerosis (MS) can cause the reactivation of the polyomavirus JC (JCPyV); this may result in the development of progressive multifocal leukoencephalopathy (PML), a rare and usually lethal disease. JCPyV infection is highly prevalent in worldwide population, but the...
Gespeichert in:
| Veröffentlicht in: | Viruses |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000901/ https://ncbi.nlm.nih.gov/pubmed/33809082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13030468 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|